Thomas J. Schall
2010
In 2010, Thomas J. Schall earned a total compensation of $1.7M as President and Chief Executive Officer at ChemoCentryx.
Compensation breakdown
| Non-Equity Incentive Plan | $162,000 |
|---|---|
| Option Awards | $1,106,281 |
| Salary | $450,000 |
| Other | $690 |
| Total | $1,718,971 |
Schall received $1.1M in option awards, accounting for 64% of the total pay in 2010.
Schall also received $162K in non-equity incentive plan, $450K in salary and $690 in other compensation.
Rankings
In 2010, Thomas J. Schall's compensation ranked 3,524th out of 10,439 executives tracked by ExecPay. In other words, Schall earned more than 66.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,524 out of 10,439 | 66th |
Division Manufacturing | 1,225 out of 3,838 | 68th |
Major group Chemicals And Allied Products | 238 out of 921 | 74th |
Industry group Drugs | 132 out of 680 | 81st |
Industry Pharmaceutical Preparations | 101 out of 481 | 79th |
Source: SEC filing on April 27, 2012.
Schall's colleagues
We found two more compensation records of executives who worked with Thomas J. Schall at ChemoCentryx in 2010.